# Desmopressin

## Minirin inj 4mcg/1mL (DDAVP)

##### 

| TAH Drug Code      | IDDA                                                                                                                                                                                                                                                                                                                                                           |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Central Diabetes Insipidus, Primary Nocturnal Enuresis, Renal Concentrating Capacity Test,Symptomatic treatment of nocturia in adults associated with nocturnal polyuria ie, nocturnal urine production exceeding bladder capacity. Hemophilia A and von Willebrand's Disease                                                                                  |
| Dosing             | Central diabetes insipidus: Adult: 1-4mcg(0.25-1mL) ; Children > 1 year 0.4-1mcg(0.1-0.25mL) ; Children < 1 year 0.2-0.4mcg(0.05-0.1mL), 1-2 times per day .Patients with mild to severe hemophilia or drug-induced platelet dysfunction: 0.3mcg/kg diluted with normal saline to 50-100mL, IV infusion for over 15-30 minutes, could repeat after 6-12 hours. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                  |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                       |
| Contraindications  | Habitual & psychogenic polydipsia, syndrome of inappropriate ADH secretion (SIADH), known hyponatremia, known or suspected cardiac decompensation & other conditions that require diuretics, moderate & severe renal impairment.                                                                                                                               |
| Adverse Effects    | Nausea, abdominal pain, headache, nasal congestion/rhinitis, nose bleeds. Nasal spray May cause bronchospasm due to the presence of benzalkonium Cl. Dermatologic: Flushing Gastrointestinal: Nausea, Will respond to dosage decrease Neurologic: Fatigue (10% ), Headache (22.5% )                                                                            |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                         |
| Lactation          | Compatible                                                                                                                                                                                                                                                                                                                                                     |

## Minirin Melt 60mcg 凍晶口溶錠

##### 

| TAH Drug Code      | OMIN6                                                                                                                                                                                                                                                                                                                                                                   |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | 主治尿崩症、夜尿症 Central Diabetes Insipidus, Primary Nocturnal Enuresis, Renal Concentrating Capacity Test,Symptomatic treatment of nocturia in adults associated with nocturnal polyuria ie, nocturnal urine production exceeding bladder capacity. Hemophilia A and von Willebrand's Disease                                                                        |
| Dosing             | Central diabetes insipidus: Initial dose as 60mcg three times per day, followed by 60-120mcg three times per day as maintain dose.(Total daily dose:120mcg-720mcg.) Primary nocturia: 120mcg at bedtime, up to 240mcg if needed. Nocturia: 60mcg at bedtime, up to 120mcg after one week & subsequently 240mcg weekly dose escalations.To be administered sublingually. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                           |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                |
| Contraindications  | Habitual & psychogenic polydipsia, syndrome of inappropriate ADH secretion (SIADH), known hyponatremia, known or suspected cardiac decompensation & other conditions that require diuretics, moderate & severe renal impairment.                                                                                                                                        |
| Adverse Effects    | Nausea, abdominal pain, headache, nasal congestion/rhinitis, nose bleeds. Nasal spray May cause bronchospasm due to the presence of benzalkonium Cl. Dermatologic: Flushing Gastrointestinal: Nausea, Will respond to dosage decrease Neurologic: Fatigue (10% ), Headache (22.5% )                                                                                     |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                  |
| Lactation          | Compatible                                                                                                                                                                                                                                                                                                                                                              |

